News

Tezepelumab, a monoclonal antibody targeting thymic stromal lymphopoietin approved for add-on severe asthma treatment in 2021 ...
Nifty Pharma stocks, including GSK, Jubilant Pharmova, Eris Life, Gland Pharma and Torrent Pharma, saw gains up to 8% as ...
Prosecutors said there was a trail of blood inside her home that led to the sidewalk where her body was discovered.
The Japanese Ministry of Health, Labour and Welfare (MHLW) has granted approval for the use of GSK’s Blenrep (belantamab ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
Peter Humphrey, a former journalist and private investigator, believes a Chinese surveillance team were monitoring his group ...
“This is a high-quality study that stands out mainly for its sample size. The results confirm previous findings that people with a history of cold sores have a higher risk of developing Alzheimer’s ...
The Dementia Discovery Fund ("DDF"), managed by SV Health Investors, today announced the final closing of its second fund, DDF-2, with $269m in commitments. DDF is the world's largest family of ...
U.S. FDA clears lung cancer IND for CVHNLC, a proprietary off-the-shelf candidate targeting squamous non-small cell lung cancer (sqNCLC), with clinical study expected to begin H2 2025; Clinical Trial ...
Microsoft launches Discovery, its new enterprise AI platform from Build 2025, set to accelerate scientific R&D via collaborative AI agents & a graph-knowledge engine for faster innovation.
Current treatment paradigms for lupus nephritis offer significant room for improvement, according to a presenter at the ...
The Coaltion for Global Hepatitis Elimination's National Hepatitis Elimination Profiles assess the status of national data, ...